Prophase labs hires dr. matthew halpert to drive company's key therapeutic and diagnostic oncology programs

Garden city, ny, may 08, 2023 (globe newswire) -- prophase labs, inc. (nasdaq: prph), a next generation biotech, genomics and diagnostics company, today announced that dr. matthew halpert has been hired as a full-time consultant to drive the company's key therapeutic and diagnostic programs forward which will comprise the backbone of prophase's efforts in both advanced cancer therapeutics and targeted cancer diagnostics.
PRPH Ratings Summary
PRPH Quant Ranking